Laurus Labs has agreed to buy Aspen Pharmacare's Phekolong Pharmaceuticals South African subsidiary for just ZAR75,000 ($5,075) in cash. The vertically integrated Indian player says the transaction, which it expects to complete in November, will give it “access to the South African public antiretroviral sector, which manages the world’s largest public ARV program.”
South Africa’s Aspen will continue to manufacture finished-dose ARVs for the country’s public sector, but distribution will now take place...
